Auranofin
1 Inquiries
34031-32-8
98%
2026-07-18
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName Auranofin Cat No CEI-0552 Description An anti-arthritic drug that inhibits various leukocyte activation pathways at multiple sites. Inhibits release of inflammatory mediators from human basophils, pulmonary mast cells and macrophages. Also inhibits human neutrophil 5-lipoxygenase. Inhibits IκB kinase (IKK) by modifying Cys179 of the IKKß subunit. Efficient inducer of mitochondrial membrane permeability transition via the inhibition of mitochondrial thioredoxin reductase (TrxR). Alias SKF39162 Appearance Red solid Product Overview Leukocyte activation pathways inhibitor CAS No 34031-32-8 Molecular Weight 445.42 Purity >98% by NMR Storage -20 centigrade Synonyms SKF39162 Targets Leukocyte activation pathways Molecular Formula C20H34AuO9PS Chemical Name 1-Thio-β-D-glucopyranosatotriethylphosphine gold-2,3,4,6-tetraacetate Solubility DMSO (25 mM) Shipping Conditions Gel pack category Antipyretic Analgesics(c1413) cas_num 34031-32-8 Basic Info-
Product Name:
Auranofin
Other Name:Gold,[1-(thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)-;Gold,(1-thio-β-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-;Gold,(1-thio-β-D-glucopyranosato)(triethylphosphine)-,2,3,4,6-tetraacetate;β-D-Glucopyranose,1-thio-,2,3,4,6-tetraacetate,gold complex;[1-(Thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold;[(Tetra-O-acetyl-β-D-glucopyranosyl)thio](triethylphosphine)gold;SKF 39162D;Auranofin;Ridaura;SKF 39162;Crisofin;Crisinor;Aktil;Ridauran;NSC 321521;Gold Salt
CAS No.:34031-32-8
Molecular Formula:C20H34AuO9PS
InChIKeys:InChIKey=AUJRCFUBUPVWSZ-XTZHGVARSA-M
Molecular Weight:678.48
Exact Mass:679.140511
EC Number:251-801-9
NSC Number:321521
DSSTox ID:DTXSID4020115
Color/Form:White crystalline powder
ATC Code:M - Musculo-skeletal system
Categories:
Characteristics-
Melting Point:
112-115 °C
Boiling Point:425.5°C at 760 mmHg
Flash Point:298ºC
Water Solubility:DMSO: ≥5mg/mL
Storage Conditions:room temp
Toxicity:Oral-rat LD50:265 mg/kg; Oral-Mouse LD50; 310 mg/kg
Flammability characteristics:Combustible; burning produces toxic nitrogen oxides and sulfur oxide fumes; patient side effects are: stomach bleeding and stomach ulcers
Odor:Odorless
Experimental Properties:Unstable to light and heat
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Commercially available auranofin capsules should be stored in tight, light-resistant containers at 153 deg C.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Russia
Auranofin
50 G Mar 6, 2025 Post an enquiry for this product
